Keiretsu Forum Northwest
VC Fund
Seattle, United States
Keiretsu Forum Northwest is a VC fund in Seattle focused on Health Care and Software. Keiretsu Forum is a community of private equity investors, business leaders and entrepreneurs with a network of over 50 global chapters and more than 2,500 investor members.
- Total investments:
- 138
- Last investment:
- Lead investor:
- 4%
Last updated:
For AI agents: llms.txt
Industries Keiretsu Forum Northwest invests in
Stages Keiretsu Forum Northwest invests in
Countries Keiretsu Forum Northwest invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 8 contacts → | |||
Round size
- Seed
- $200k–$2M
- Series A
- $500k–$8M
- Venture - Series Unknown
- $650k–$5M
Investment Focus
Industry
- Health Care 28 (20%)
- Software 23 (17%)
- Biotechnology 17 (12%)
- Manufacturing 14 (10%)
- Medical Device 13 (9%)
Stage
- Series A 51 (37%)
- Seed 30 (22%)
- Venture - Series Unknown 27 (20%)
- Series B 8 (6%)
- Funding Round 7 (5%)
Country
- United States 97 (70%)
- Spain 8 (6%)
- Canada 7 (5%)
- Israel 6 (4%)
- India 2 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Don Megrath
Portland OR Chapter Co-President
|
Portland OR Chapter Co-President | Total investments: 0 | Find email | |
Juan Arango
Entrepreneur Director
|
Entrepreneur Director | Total investments: 0 | Find email | |
Loren Lyon
Bellevue/Eastside Chapter President
|
Bellevue/Eastside Chapter President | Total investments: 0 | Find email | |
Matthew Housser
Member
|
Member | Total investments: 0 | Find email | |
Michael Volker
Vancouver BC Chapter Co-President
|
Vancouver BC Chapter Co-President | Total investments: 2 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| iQure Pharma is a global biotech company created by entrepreneurs and former pharma managers that focuses on the development of new therapeutics. | $600K / Series A / Aug 30, 2022 | ||
| Vartega is a technology development company specializing in the carbon-fiber-reinforced plastic recycling process. Vartega develops alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass-market applications.Vartega's patented carbon fiber recycling process scales rapidly to fill a gap in thecomposites supply chain. The company’s carbon fiber is available in semi-continuous, chopped, and milled forms. It is ideally suited for use in thermoplastics, non-wovens, and molding compounds. | Seed / Dec 01, 2021 | ||
| Levered Learning is a classroom-tested and teacher-designed instructional system providing 3rd-5th grade mathematical learning. The company was founded in 2017 by Mitch Slater and is headquartered in Soquel, California, United States. | $1.5M / Seed / Oct 07, 2021 | ||
| Inmedix has discovered and is commercializing a novel class of diagnostics and therapeutics. Their approach focuses on autonomic nervous system (ANS) control of stress responses within the brain. In the setting of an autoimmune disease, ANS stress can significantly intensify an autoimmune disease. They call it Immuno-autonomics. They seek tounderstand and block this process to allow current autoimmune disease therapies to work much better. | $2.7M / Angel / Jan 01, 2019 | ||
| Vita is an aerospace company that builds autonomous systems for helicopter hoisting and sling load missions. | $1.2M / Seed / Sep 30, 2018 | ||
| SageMedic develops a genome-free SAGE Direct Platform that introduces the next generation of precision medicine by directly testing effective cancer treatments on a live tissue biopsy of a patient. | Convertible Note / Aug 29, 2018 | ||
| CleanFiber is a construction manufacturing company that makes building insulation from recycled corrugated cardboard. They are preparing to launch their first facility and they have customer commitments. The company was founded in 2013 and headquartered in Buffalo, New York. | $5M / Venture - Series Unknown / Mar 27, 2018 | ||
| Novuson, a spinout from the University of Washington’s highly regarded Applied Physics Laboratory’s Center for Industrial and Medical Ultrasound, is developing its Direct Therapeutic Ultrasound (DTU) technology platform for coagulation and hemostatic control in surgical and trauma procedures. DTU technology should enable clinicians to performsurgeries more quickly and to rapidly control bleeding associated with traumatic injuries. The company founders are Stuart B. Mitchell, PhD. and Francesco P. Curra, Ph.D.Novuson creates tools that reduce operational cost and operating time, eliminating bleeding complications and enhancing patient outcomes. These automatic devices use direct therapeutic ultrasound energy for fast and robust hemostasis, cauterization and division. The devices cauterize tissue from the inside out, creating a well-defined, controlled plane of cauterization. The company was founded in 2014 and based in Bothell, Washington. | Convertible Note / Oct 03, 2017 | ||
| Hemex Health is a provider of a diagnostic device designed for populations at risk for malaria and sickle cell disease. The company's portable diagnostic device can be used by physicians, small labs and field healthcare workers to detect and treat malaria and sickle cell diseases more rapidly than current tests, enabling patients to receiveaffordable, life-changing medical diagnostics treatment. | $3M / Seed / Jun 29, 2017 | ||
| Touchjet software platform that offers cloud services and touchscreen interactivity for its clients to be interactive on conference rooms and classrooms and enable digital collaboration. Its cloud services provide access to digital content wherever its users are. The company was founded in 2013 and headquartered Campbell, Califotnia. | Series A / May 24, 2017 | ||
| See all 138 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Keiretsu Forum Northwest invest in?
Keiretsu Forum Northwest invests primarily in Health Care, Software and Biotechnology startups, most often at Series A and Seed stage. Most of the 138 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Keiretsu Forum Northwest's check size?
Keiretsu Forum Northwest typically joins rounds of $200k–$2M at Seed, $500k–$8M at Series A and $650k–$5M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Keiretsu Forum Northwest participates in.
How do I contact Keiretsu Forum Northwest?
Public channels for Keiretsu Forum Northwest include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Keiretsu Forum Northwest?
The team at Keiretsu Forum Northwest includes Don Megrath (Portland OR Chapter Co-President), Juan Arango (Entrepreneur Director) and Loren Lyon (Bellevue/Eastside Chapter President), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
